• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
OPK

OPK

OPKO Health, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.46

+0.06 (+4.29%)

Rating:C

Company Profile

CEO

Phillip Frost

IPO Date

1995-11-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.39

Prev. Close

$1.40

Day Low

$1.37

Day High

$1.47

52W Low

$0.98

52W High

$1.60

Market Cap

$1.10B

Volume

4.49M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

26.1%

Avg Negative

15.7%

Avg Neutral

58.3%

News Feed

Why Opko Health Shares Shriveled by Nearly 8% on Friday

The Motley Fool·7/30/2021·↓ negative

OPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down

Zacks Investment Research·7/30/2021·↑ positive

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

OPKO Health (OPK) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research·7/29/2021·↑ positive

OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results

GlobeNewsWire·7/29/2021·↓ negative

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

GlobeNewsWire·7/20/2021·↓ negative

Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week

The Motley Fool·7/16/2021·↓ negative

OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy

Benzinga·7/12/2021·↑ positive

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

GlobeNewsWire·7/12/2021·↑ positive

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

GlobeNewsWire·7/8/2021·↑ positive